08:00 , Feb 11, 2008 |  BC Week In Review  |  Company News

Calibrant, Yale University deal

Calibrant and the university will use Calibrant's Gemini protein profiling platform to identify ovarian and breast cancer drug targets from tissue samples. The parties will share ownership of resulting IP, which Calibrant has an option...
08:00 , Feb 4, 2008 |  BC Week In Review  |  Company News

Calibrant, The Cleveland Clinic deal

The parties will use Calibrant’s Gemini proteomics platform to identify prognostic biomarkers and therapeutic targets from glioblastoma multiforme (GBM) samples provided by the clinic. Ownership of resulting IP will be determined by inventorship. Calibrant has...
08:00 , Jan 28, 2008 |  BC Week In Review  |  Company News

Calibrant management update

Calibrant Biosystems Inc. , Gaithersburg, Md.   Business: Proteomics, Cancer   Promoted: Brian Balgley to chief technology officer from director of proteomics  ...